Abbott Laboratories (FreeStyle Libre)
Abbott Laboratories (FreeStyle Libre) (ABT) is a publicly traded Connected Wearables company founded in 1888 and based in Abbott Park, United States.
Abbott's FreeStyle Libre continuous glucose monitoring system is the most widely used CGM globally, with a sensor-based wearable and mobile app for real-time glucose tracking. NYSE: ABT (est. 1888). Libre drives ~$6B in annual diabetes care revenue. Libre 3 received FDA clearance. Lingo OTC CGM for wellness launched 2024. Global installed base exceeds 5M users.
FreeStyle Libre drives the consumer-accessible CGM market and competes directly with DexCom; Abbott's broader diagnostics and medical device portfolio means Libre benefits from unmatched distribution in retail and international markets.
freestyle.abbott ↗·Connected Wearables·
United States·public · ABT 
